Overview
Michael Dowling is a Neurologist in Dallas, Texas. Dr. Dowling is rated as an Experienced provider by MediFind in the treatment of Metachromatic Leukodystrophy. His top areas of expertise are Stroke, Moyamoya Disease, Seizures, Thrombectomy, and Craniectomy.
His clinical research consists of co-authoring 66 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MANAGED MEDICAID PLAN
- EPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2350 N Stemmons Fwy, Ste F5400, Dallas, TX 75207
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UT Southwestern - Neurology
Saima Kayani is a Neurologist and a Pediatrics provider in Dallas, Texas. Dr. Kayani is rated as a Distinguished provider by MediFind in the treatment of Metachromatic Leukodystrophy. Her top areas of expertise are Leigh Syndrome, CLN5 Disease, CLN4 Disease, and CLN1 Disease.
Texas Neurology, P.A.
Dr. Schiffmann is a renowned expert on neurometabolic diseases. He earned his medical degree from the University of Liège, Belgium and a Master of Health Sciences in Clinical Research from Duke University. He is board-certified in Neurology with a Special Qualification in Child Neurology and is a Fellow of the American Academy of Neurology. Dr. Schiffmann was a lead researcher at the United States National Institutes of Health in Bethesda, Maryland for over 17 years (1991-2007) and then the Director of the Institute of Metabolic Disease at the Baylor Scott & White Research Institute in Dallas, Texas, 2008-2019. Dr. Schiffmann is a Professor in the Department of Internal Medicine, Texas Christian University and a Clinical Professor, Texas A&M University Medical School College of Medicine. He is also a Senior Vice President for Clinical Research at 4D Molecular Therapeutics. Dr. Schiffmann has been performing pre-clinical and clinical research on lysosomal storage diseases since 1991 with a special focus on the natural history, pathogenesis and therapy of Fabry disease, Gaucher disease and the leukodystrophies. One of his particular interests and areas of expertise is to address patients with undiagnosed neurological diseases. Dr. Schiffmann has published 276 peer-reviewed research articles and over 15 book chapters. Dr. Schiffmann is rated as an Elite provider by MediFind in the treatment of Metachromatic Leukodystrophy. His top areas of expertise are Gaucher Disease Type 3, Fabry Disease, Gaucher Disease, and Leukodystrophy.
UT Southwestern Medical Center
Brendan Kelley is a Neurologist in Dallas, Texas. Dr. Kelley is rated as a Distinguished provider by MediFind in the treatment of Metachromatic Leukodystrophy. His top areas of expertise are Lewy Body Dementia (LBD), Cerebellar Degeneration, Neuronal Intranuclear Inclusion Disease (NIID), and Alzheimer's Disease.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Moyamoya DiseaseDr. Dowling isDistinguished. Learn about Moyamoya Disease.
- StrokeDr. Dowling isDistinguished. Learn about Stroke.
- Advanced
- 3MC SyndromeDr. Dowling isAdvanced. Learn about 3MC Syndrome.
- Acrocallosal SyndromeDr. Dowling isAdvanced. Learn about Acrocallosal Syndrome.
- Agyria Pachygyria PolymicrogyriaDr. Dowling isAdvanced. Learn about Agyria Pachygyria Polymicrogyria.
- Aicardi SyndromeDr. Dowling isAdvanced. Learn about Aicardi Syndrome.
- AnemiaDr. Dowling isAdvanced. Learn about Anemia.
- AphantasiaDr. Dowling isAdvanced. Learn about Aphantasia.
- Experienced
- 2q37 Deletion SyndromeDr. Dowling isExperienced. Learn about 2q37 Deletion Syndrome.
- 47 XYY SyndromeDr. Dowling isExperienced. Learn about 47 XYY Syndrome.
- Aase SyndromeDr. Dowling isExperienced. Learn about Aase Syndrome.
- Abruzzo-Erickson SyndromeDr. Dowling isExperienced. Learn about Abruzzo-Erickson Syndrome.
- Absence SeizureDr. Dowling isExperienced. Learn about Absence Seizure.
- Acrodermatitis EnteropathicaDr. Dowling isExperienced. Learn about Acrodermatitis Enteropathica.

